Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SB returns to Aradigm control of phase II development of pain management system

Dec. 19, 2000

Dipeptide caspase, apoptosis inhibitors designed by Cytovia research team

Dec. 18, 2000

Guilford seeks E.U. approval to begin trials of novel anesthetic and analgesic agents

Dec. 18, 2000

Forest reports successful completion of phase III escitalopram clinical trial

Dec. 18, 2000

FDA clears new dose of Concerta for ADHD

Dec. 18, 2000

More PARP inhibitors identified at BASF

Dec. 15, 2000

Ivax licenses cladribine for MS

Dec. 15, 2000

Centrally acting muscle relaxants acting via 5-HT receptors discovered at Eisai

Dec. 14, 2000

Vascular effects of first- and second-generation triptans compared in migraine patients

Dec. 14, 2000

Fujisawa announces Japanese launch of Myslee

Dec. 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...